Characterization of patients who received further adjuvant endocrine therapy after 5 years of aromatase inhibitors (AIs): NCIC CTG MA 27.
Steven E. Vogl
No relevant relationships to disclose
Abdullah Khalaf Altwairgi
No relevant relationships to disclose
Judy-Anne W. Chapman
No relevant relationships to disclose
Liting Zhu
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Paul Edward Goss
Honoraria - Novartis; Pfizer